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Abstract
The gold standard in the diagnosis and treatment of proctological diseases is the 
exploration of the anal canal and distal rectum under anaesthesia (EUA), routinely 
performed as day case surgery. In selected cases it can be conducted as an outpatient 
exploration (OE) during a specialist surgical consultation. In the outpatient setting 
it is possible and safe to perform rubber band ligation, sclerotherapy and infrared 
coagulation for the treatment of haemorrhoidal disease, excision and incision of 
thrombosed external haemorrhoids, abscess drainage, setonage and fistulotomy 
also in case of perianal Crohn’s disease, anal warts and skin tags removal. In terms 
of patients’ satisfaction and success rate OE is comparable to EUA. All procedures 
can be performed under local anaesthesia. Pain control after the procedure is 
provided by oral pain killers.
Keywords: outpatients exploration, haemorrhoids, abscess and anal fistula, skin tags, 
anal warts, perianal Crohn’s disease
1. Introduction
In the last decades, efforts and resources have been focused on developing health 
care services, resulting in newer facilities, greater resources of equipment and 
improved staffing, so that nowadays, surgical procedures can be carried out in large 
hospitals, providing both surgeons and patients safety and comfort. Consequently, 
not only major surgical interventions, but also minor procedures not requiring 
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preoperative preparation, special equipment, nor hospital stay, are performed in 
these hospitals, thus tremendously increasing both the costs of medical treatment 
and the length of waiting lists for hospitalisation [1].
Recently, attention has shifted to outpatient care aiming to ensure safe surgical 
and medical assistance at reduced costs, spared resources and in shorter waiting 
times, through both office-based procedures, which include minor operation per-
formed under local anaesthesia, requiring a short time to discharge (ranging from 
minutes to hours after the procedure) and day-surgery interventions, encompassing 
surgical operations more complex than office-based procedures, but easier than 
major surgery requiring at least an overnight stay [1, 2].
During the last 30 years, government with the support of health insurance com-
panies, medical groups and hospital associations focused their concerted efforts on 
the development of proctologic office-based procedures in order to reduce hospital 
costs and release beds for major surgeries. While almost 30–50% of all surgeries 
can be safely realised in outpatient sectors, this rate raises to 90% in anorectal 
operations [1]. In fact, even if complications rate following anorectal office-based 
procedures are extremely variable, the majority of them are minor complications 
and do not require hospitalisation, nor further surgical intervention.
Factors appealing to physicians include significant costs saving achieved 
avoiding the cost of admission, use of ward-based supplies, respiratory therapy, 
increased medication costs, and laboratory charges. Other advantages include 
lack of need to perform trichotomy, prophylactic antibiotic treatment, and enema 
administration. Moreover, also patients’ satisfaction degree is increased thanks to 
the ease of scheduling cases, the advantage of avoiding a hospital stay and the early 
return home [1, 3].
However, to perform ambulatory anorectal surgery, a proper patient selection 
is necessary. Patient comorbidities as well as functional limitations should be 
assessed. The type and extent of surgery should be considered since not all anorec-
tal procedures are minor [3].
2. Patient position
Patient positioning during proctologic assessment is important for patients and 
doctors. Patients undergoing both proctologic examination and ambulatory proce-
dures are usually embarrassed because they lay naked on uncomfortable position, 
that can be:
• Sims’ position, or left lateral position
• Lithotomy position with lifted legs, or gynaecological position
• Knee–chest position
• Knee–chest position with patients body bent forward, or jack-knife position
Even though the majority of individuals would favour Sims’ position if they had 
the choice, they do not feel less embarrassed, thus preferring to let doctors free to 
choose the most suitable position to get reliable diagnoses of anal complaints [4]. 
The most performed positions are left lateral Sims’ position and jack-knife position. 
The former is more comfortable for the patients and is easily and quickly achieved 
by the patient itself, allowing doctors to save time. This position is the most suit-
able to analyse haemorrhoids, but can be adapted to each proctologic disease. The 
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jack-knife position, on the contrary, requires a scissoring table able to lift the hip, 
letting head and legs down and takes more time to be obtained. The sloping position 
of the patient makes it difficult to analyse haemorrhoids, however as the buttocks 
fall to each side, and finger tips of both hands of the investigator are free, it provides 
a better field of view on anal and perianal surface in good lighting. Since sensitiv-
ity, specificity, and the predictive value of anal diagnoses in different proctologi-
cal positions are unknown, and considering that none of different proctological 
positionings are most embarrassing to patients, doctors choice usually depends on 
their own customs and preferences.
3. Anaesthesia
Ambulatory anaesthesia has to provide a rapid onset analgesic effect, ensuring pain 
control and allowing an early discharge after the treatment is performed. The choice of 
the intra-operative anaesthetic management should consider patient’s related factors, 
such as age, clinical condition and preference, surgeons’ preference and procedural 
related factors, such as the kind of treatment and its length [5]. Anaesthesia for ambu-
latory procedures ranges from local to loco-regional anaesthesia, including pudendal 
nerve block and posterior perineal block; however, the easiest and shortest therapeutic 
sessions could even be performed without any anaesthesia, paying attention to the 
post-operative management, especially in terms of post-operative pain control.
Local anaesthesia is obtained through subcutaneous, intradermal or submu-
cosal 1% lidocaine injections. Complications rate following local anaesthesia are 
extremely low, thus allowing to safely perform it in an outpatient setting. They 
include pain, which is usually due to the injected anaesthetic volume causing 
tissue distension, allergic reactions, and infections. Cardiovascular collapse is a 
rare but potentially life-threatening complication, requiring promptly intubation 
and vosoactive substances, steroids and myorelaxant drugs administration. Local 
anaesthesia is a quick and easy to perform anaesthesia, that allows performing 
minor ambulatory procedures, keeping pain under control.
Loco-regional anaesthesia includes pudendal nerve block and posterior perineal 
block. Pudendal nerve block, firstly described by Mueller in 1908, is performed 
with the patient in gynaecological position and is usually preceded by local anaes-
thesia administration if carried out in an ambulatory setting to an awake patient. 
After identifying the ischial spine, the needle punctures the skin transperineally, 
medial to the ischial tuberosity, 2–3 centimetres away from the anal margin. The 
needle is advanced in the posterolateral direction until the ischial spine and then 
rotated in the medial inferior direction to the ischial spine, passing through the 
sacrospinous ligament. After negative aspiration, the local anaesthetic, usually 
ropivacaina, is injected. Posterior perineal block, also known as Marti’s technique, 
is performed with the patient in gynaecological or lithotomic position and preceded 
–in case of outpatient setting, by local anaesthesia administration, just as for puden-
dal nerve block. It involves infiltration of the inferior hemorrhoidal nerves, the 
posterior branch of the internal pudendal nerves, and the anococcygeal nerves and 
block of the inferior gluteal nerves and of perineal branches of minor nerves from 
the sacral plexus. It is achieved injecting ropivacaina or lidocaine 2 cm from the anal 
verge in the posterior commissure, 8 to 10 centimetres deeply into each ischiorectal 
fossa and superficially in the anterior commissure to achieve a complete infiltra-
tion of the perineal skin. Loco-regional anaesthesia is usually suitable to perform 
exploration under anaesthesia (EUA) of the anal canal in operative theatre and 
is associated to general anaesthesia to reach a complete multimodal pain control. 
In the ambulatory setting loco-regional techniques are unfrequently used, but 
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sometimes may be required to perform more invasive treatments. Complications are 
the same as for local anaesthesia, thus even if more invasive than local anaesthesia, 
these techniques may be safely performed for outpatient treatment.
4. Postoperative management
Postoperative management after proctologic office-based procedures mostly 
focuses on post-procedural pain control. It starts with anaesthesia performed dur-
ing the procedure, so that the dose of analgesic drugs thereafter required is reduced 
and recovery time and return to daily living activities are shortened. After office-
based procedures the pain can be controlled with oral pain killers administration. 
While the use of non-steroidal anti-inflammatory drugs (NSAIDs) alone is poorly 
effective to control severe pain and the use of narcotics alone may cause various side 
effects such as nausea, vomiting, dizziness and constipation (thus ultimately exac-
erbating pain symptoms), multimodal or balanced analgesia is the most effective 
treatment. It consists of administering in addition to narcotics, drugs with different 
mechanisms of actions and target pathways, including NSAIDs, acetaminophen, 
gabapentinoids, dexamethasone, alpha 2 agonists, NMDA receptor antagonists, 
and duloxetine. Acetaminophen and NSAIDs such as ketorolac and ibunoprofen 
successfully manage pain, resulting in an effective narcotic-sparing approach. 
The administration of pain killers drugs belonging to different classes results in 
increased analgesic effect and reduced drugs-induced side effects [5–7].
Analgesia may be provided by lidocaine and prilocaine ointment, too, ensuring 
supplemental pain relief and furtherly sparing narcotics.
Besides oral pain killers administration and local analgesic ointments applica-
tion, anal burning and patient satisfaction may be improved by warn sitz baths. 
They are considered a worthwhile potential adjunct with little associated risk even 
if do not significantly reduce actual pain. Sitz baths or showers starting within 
24 hours of the operation should be performed three times per day and after bowel 
movements for comfort and cleanliness [8].
Finally, to ensure pain control, it is fundamental to avoid constipation. Usually 
increased dietary fibre and fluid intake is sufficient to reduce postoperative con-
stipation and pain upon defecation. However, even if dietary modification could 
guarantee stool softening, some physicians feel more comfortable recommending 
stimulant laxatives and stool softeners [5].
Postoperative management includes also follow-up instructions and written 
discharge instructions, improving patient satisfaction and decreasing the need for 
patients to seek additional medical attention, thus even reducing costs.
5. Haemorrhoids
Haemorrhoids are arteriovenous sinusoids, located in the sub-epithelial space, 
embedded in connective tissue and smooth muscle fibres, participating to 15–20% 
of the anal continence [9–12]. Haemorrhoidal disease (HD) is characterised by 
abnormally congested and downward displaced haemorrhoids [11–13].
HD is one of the most frequent medical and surgical diseases and the com-
monest proctologic disease, experienced by more than 50% of the population over 
50 years old in various degree. Reports on HD prevalence rate widely varies (4,4–
39%) [9, 14–16] because clinical manifestations may overlap with those of others 
anorectal diseases and may be wrongly attributed to other proctologic conditions; 
moreover many patients are asymptomatic, not requiring any treatment, while 
others self-diagnose and self-manage without referring to a specialist.
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Increased intraabdominal pressure due to constipation and prolonged straining are 
the commonest conditions leading to haemorrhoidal disease because of obstruction of 
venous return, resulting in engorgement of the haemorrhoidal plexus [17]. Moreover, 
defecation of hard faecal material increases shearing force on the anal cushions.
Painless rectal bleeding is the commonest onset of haemorrhoidal disease, which 
may present as minimal bright red bleeding per rectum or hematochezia after bowel 
movements [18–20], or even severe acute lower gastrointestinal bleeding requiring 
hospitalisation and blood transfusion in the most severe cases [17, 19]. Although 
rectal bleeding is the commonest sign of HD, less frequent presentations may be 
prolapse (even determining difficult defecation), mucous discharge, swelling, 
soiling, perianal skin irritation, itching, feeling of a lump, and discomfort. Acute 
anal pain is rarely a presentation symptoms, appearing only in case of thrombosed 
external haemorrhoids.
Despite such a variable clinical onset, HD diagnosis is easily achieved collecting 
the medical history and performing a physical examination including abdominal 
examination, and a local examination with the patient on a left lateral position, 
including inspection of the perianal tissues, anorectal digital examination, and anos-
copy. However, even if haemorrhoids are easily recognised, it is necessary to perform 
an endoscopic examination to exclude more severe colorectal conditions [17].
Once HD has been diagnosed, the chosen treatment depends on haemorrhoids 
location, on the severity of the disease and on an eventual previously administered 
treatment. Haemorrhoids location refers to the dentate line, allowing a distinction 
between internal (above the dentate line and covered with mucosa) and external 
haemorrhoids (below the dentate line and coated with squamous epithelium), 
which differ not only for their position, but also blood supply, drainage, epitheliza-
tion and innervations [20]. In particular, internal haemorrhoids receive visceral 
innervations and are less sensitive to pain, thus amenable to office-based treatment 
performed without or with minimal anaesthesia. On the contrary, external haemor-
rhoids are more sensitive to pain receiving somatic innervations and, therefore, 
require surgical treatment performed under anaesthesia, thrombosed external 
haemorrhoids being the only exception.
Regarding to haemorrhoids severity, while no widely accepted classification exists 
for external haemorrhoids, the extent of internal haemorrhoids is usually assessed 
with the Goligher classification [10, 17, 21], depending on the degree to which they 
prolapse from the anal canal, so that bleeding without prolapse stands for grade I, 
haemorrhoidal piles prolapsing during straining correspond to grade II and III if they 
respectively reduce spontaneously or manually, and non reducible haemorrhoids are 
classified as grade IV. As the grade becomes worse, office-based procedures or surgery 
are required. In particular grade I treatment is usually conservative, grade II and III 
are amenable of office-based procedures, and grade IV haemorrhoids require surgery.
However, even if the chosen treatment depends on both haemorrhoids location 
and severity degree, usually the first therapeutic step is conservative and consists on 
dietary and lifestyle modifications, if necessary associated to topical or oral medica-
tion. Conservative treatment is successful for the majority of patients and could be 
periodically administered for as long as the patient wishes. If conservative treat-
ment fails or the patient chooses a more invasive approach, office-based procedures 
or surgery are indicated [12, 14, 22].
5.1 Outpatient treatment
Outpatient treatment is recommended for symptomatic patients affected by grade 
I, II or III haemorrhoidal disease refractory to conservative treatment [12, 14, 22]. It 
encompasses rubber band ligation, sclerotherapy, infrared coagulation, excision of 
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thrombosed external haemorrhoids and few other techniques, not frequently used, 
such as electrotherapy, HET bipolar system, YAG or carbon dioxide laser and cryo-
surgery [23]. Their common aim is to slough haemorrhoidal tissue and generate a scar 
so that residual tissue is fixated to the underlying sub-mucosal tissue and anorectal 
muscular ring. Each procedure is adopted in specific circumstances, being rubber 
band ligation the most frequently performed with a wider therapeutic range. Even if 
they differ for technical features and indications, all the office-based procedures are 
characterised by faster recovery and less pain than surgical treatment [24]. Moreover, 
complication rate following outpatient treatment is extremely low, varying between 
post-procedural pain –usually easy-controlled by oral painkillers, to perineal sepsis 
–the most severe and life threatening condition, which is extremely rare.
Ambulatory procedures may require more than one treatment session and can 
be repeated until a complete response, if the patient agrees. In fact, since haemor-
rhoidal disease is not a severe clinical condition, it is up to the patient whether to 
manage them with a conservative approach or surgery. Choice of the outpatient 
treatment should take into consideration patient preferences, availability of proce-
dures and fitness for further procedures. Only in case of coexisting internal haem-
orrhoids and additional anorectal pathologies surgery should be suggested as first 
line treatment [12, 14, 22].
5.2 Rubber band ligation
Rubber band ligation (RBL) is the most commonly performed office-based 
treatment, having the widest therapeutic range and the highest success rate. This 
procedure is recommended to treat almost all patients affected by symptomatic 
internal haemorrhoids refractory to conservative treatment, being contraindicated 
only in few cases:
• Grade IV internal haemorrhoids, since symptoms improvement is registered in 
less than 50% of cases
• Thrombosed haemorrhoids, characterised by excruciating pain that makes the 
procedure impossible to be performed
• Anticoagulant therapy or coagulation disorders, because of the increased risk 
of delayed haemorrhage [25]
• Immunodeficiency and diabetes mellitus, because of the increased risk of 
infection and sepsis [26]
• Concomitant anorectal diseases, for which surgery should be the first line 
treatment
• Pregnancy, usually determining a transient condition, requiring a conservative 
treatment
During the procedure, patients lay on left lateral position or semi-inverted jack-
knife position, being the former more comfortable for the patient. The anoscope is 
essential to perform the procedure, consisting on the positioning of a rubber band 
on the base of the haemorrhoid, at least 5 mm above the dentate line. The applica-
tion of the elastic band causes immediate ischemic damage and 3 to 5 days delayed 
necrosis, leading to a localised sub-mucosal scarring that secures the mucosal layers 
to the underlying tissues. Rubber band application may be performed using both 
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forceps or suction devices [27, 28]. The former represents the traditional technique 
but requires two people to be performed: the operator and the assistance, whose 
role is to hold the anoscope. The latter includes both endoscopic suction devices and 
vacuum suction devices, which allow the operator to hold both the ligator and the 
anoscope, performing the procedure without any assistant.
Usually just one pile per session is treated, in order to reduce procedure-related 
risks. Multiple sessions should be performed in 4-week intervals, to allow a com-
plete recovery from the previous treatment [29].
If the procedure is correctly performed, with the rubber band placed at least 
5 mm above the dentate line, the patient has no pain, thus the procedure can safely 
be performed without any anaesthesia. Whenever the patient experiences pain, the 
band is wrongly placed below the dentate line, onto somatically innervated tissue, 
and should promptly be removed. Beside pain, that occurs in almost 8% of the 
procedures and is most frequently due to band misplacement [30], other extremely 









RBL is the most effective office-based procedures, improving symptoms in 
93–100% of patients having grade II haemorrhoids and 78–84% of those having 
grade III haemorrhoids and reducing bleeding in up to 90% of patients [30, 35]. 
When compared to haemorrhoid artery ligation (HAL), it shows lower rates of 
bleeding, intra- and post-procedural pain, but higher risk of recurrences. The same 
has to be said comparing RBL to surgery: the former has a reduced complication risk 
compared to surgery, while the latter has lower recurrence rates [36].
5.3 Sclerotherapy
Sclerotherapy is the second most frequently performed outpatient procedure for 
haemorrhoidal disease. Since bleeding and infection risk is lower than after rubber 
band ligation, this procedure finds application whenever RBL cannot be performed, 
thus it is recommended for patients on anticoagulant therapy or coagulation disor-
ders and in case of immunodeficiency or other pathological conditions increasing 
infective risks [35].
As for RBL, the procedure is performed through an anoscope, with the patient 
laying on left lateral position. Sclerosing solutions are injected into the submucosa 
plane above the dentate line, so that the treatment does not require any anaesthesia, 
and determine an intense inflammatory reaction that leads to scarring and adhesion 
of haemorrhoids to the underlying tissue just like after ligation with elastic bands. 
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The most frequently used solutions are aluminium potassium sulphate and tannic 
acid (ALTA, which seems to be the most effective) [37–39], 5% phenol in vegetable 
oil and 50% dextrose water.
Complications following sclerotherapy are even rarer than after RBL, consid-
ering patients major complain is painful intra-procedural injection, reported in 
almost 90% of cases, while post-procedural pain is experienced only by 25–50% 
of patients. Bleeding is uncommon and in the majority of cases is a self-limited 
condition following injection. The most frequent post-operative complication is 
mucosal necrosis, which is reported in less than 4% of patients and is usually caused 
by too superficial injections (not reaching the submucosal layer). Rare but major 
complications include impotence, fatal necrotising fasciitis, rectourethral fistulas, 
and rectal perforations, that are mostly ascribed to misplaced injections –both in 
non haemorrhoidal tissue or in the vascular system [40].
Sclerotherapy successfully manage haemorrhoidal bleeding, leading to an 
improvement in 100% of patients with second and third degree haemorrhoids 
[35, 39]. Moreover it leads to a complete resolution of symptoms in 88% of I 
degree haemorrhoids and 52% III degree haemorrhoids. However, even if much 
safer than RBL and despite its high success rate, recurrences are more frequent in 
patients undergoing sclerotherapy than ligation with elastic bands, thus the latter 
resulting as the preferred choice for both surgeons and patients whenever not 
contraindicated [41].
5.4 Infrared coagulation
Infrared coagulation (IC) is an outpatient procedure indicated for the treatment 
of refractory to conservative treatment grade I, II and III haemorrhoidal disease 
[12, 14]. In literature, data regarding IC treatment are extremely variable, ranging 
from studies showing similar results as for sclerotherapy, to papers underlying 
higher recurrence rates with fewer post-procedural complications and less intra-
procedural discomfort. Thus, whether to use infrared coagulation or sclerotherapy 
depends on availability of procedures and surgeon preferences.
Infrared coagulation is also performed through an anoscope, with the patient 
laying in the same position as for the previous procedures. It consists of infrared 
light waves application on the haemorrhoidal tissue above the dentate line, which 
are converted into heat determining an immediate protein coagulation and necrosis, 
visible as 3 mm wide and 3 mm deep white spot on the mucosa. The treatment of 
each haemorrhoid cushion may require from three to five applications. As for the 
other office-based procedures, IC causes a scar fixating the redundant haemor-
rhoidal mucosa to the underlying tissues.
Complications following infrared coagulation include pain, which is the most 
frequent occurring in 16–100% of patients and bleeding, which ranges from 15 to 
45% of cases [42, 43]. Moreover, many studies report high frequency of persistency 
and recurrence after the treatment: recurrence rate is estimated to be about 15% at 
three months.
Success rates reported by a recent meta-analysis widely range from 22 to 51 and 
78%, when considering respectively grade III, II and I haemorrhoidal disease [35, 43].
5.5 Excision and incision of thrombosed external haemorrhoids
Haemorrhoidal excision is a procedure that can be performed both in an office-
based setting and in the operating theatre. It is the only office-based procedure 
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suitable for the treatment of external haemorrhoids, which are localised below the 
dentate line, have somatic innervation and thus are more sensitive to pain, making 
surgery performed in the operating theatre the best therapeutic option.
Thrombosed external haemorrhoids belong to the so called anorectal emergen-
cies. They occur with an acutely painful purplish or blue mass in the perianal area 
that gradually reduces after the first couple of days; bleeding may present in case 
the high pressure within the thrombus causes overlying skin erosion. It is important 
to differentiate this pathologic condition from complicated internal haemorrhoids 
and anal pigmented melanoma, whose onset in similar being characterised by peri-
anal pain. External haemorrhoids are covered with anoderm and usually suddenly 
appear, while internal haemorrhoids are covered with mucosa and anal pigmented 
melanoma has a long story of pigmented skin lesion [44].
Excision of the thrombosed external haemorrhoids is indicated for patients 
experiencing persistent pain from 72 hours or less, providing immediate relief [45]. 
After 48 to 72 hours, the thrombus organises and contracts, diminishing symptoms 
so that a conservative management can be proposed, obviating the need for surgi-
cal management. Surgical treatment for thrombosed external haemorrhoids may 
be required also in case of residual skin tags resulting from the healing process of 
a small ulcer following a spontaneous evacuation of a thrombosed haemorrhoid. 
However, residual skin tags rarely cause enough symptoms to warrant its removal; 
only in case of large skin tags determining skin irritation, itching, pain, or inability 
to keep proper hygiene, excision can be beneficial.
The office-based procedure to treat thrombosed external haemorrhoids 
include excision and incision. The former can be performed in the operating 
room as well as in an appropriately equipped office. After the administration  
of both local anaesthesia and anal block, the excision of a thrombosed haemor-
rhoid is performed by making an elliptical incision in the overlying skin. A 
careful dissection of the haemorrhoid from the superficial fibres of the anal 
sphincter is carried out, trying to avoid injury. Thereafter skin edges can be left 
open allowing drainage or reapproximated with absorbable sutures [46]. Topical 
antibiotic ointments are not routinely applied as infections are rare in this well-
vascularized sites.
Inexperienced physicians, unable to perform haemorrhoids excision, can man-
age this anorectal emergency with a simple incision of the overlying skin, allowing 
evacuation of thrombus, thus producing immediate relief of pain.
However, incision and evacuation of the clot is associated with a 30% risk of 
reaccumulation and thrombosis, which may disseminate to adjacent hemorrhoidal 
columns [47], thus this technique is not recommended and whenever performed 
requires a follow-up within the next 24 to 48 hours for surgical evaluation. On the 
contrary, recurrence rate for a completely excised thrombosed hemorrhoid is lower 
(5–19%) [48, 49].
If surgery is not feasible, conservative management would be offered including 
anti-inflammatory analgesics, warm sitz bath, reducing activity and avoiding consti-
pation. Education and reassurance about this condition and its benign nature would 
be beneficial to the patient.
6. Abscess and anal fistula
Abscesses and anal fistulas are common anorectal problems, representing two 
different phases of the same infectious process. Perianal and perirectal abscesses 
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are acute infections, resulting in pus collection, mostly due to non-specific 
cryptoglandular obstruction [50]. Anorectal fistulas represent the chronic evolu-
tion of a suppurative process, characterised by an epithelised tract connecting 
two epithelised surfaces, in particular anal or rectal mucosa to the perianal skin or 
perineum [51, 52].
Estimated anal abscess incidence is about 2 cases per 10,000 population per 
year [53, 54], leading to fistula formation in about 25% of patients. Fistulas may 
present de novo, but in about 30–50% of patients, they follow a previous anorectal 
abscess. Both anal abscesses and fistulas affect men twice more than women, hav-
ing a mean age of presentation of 40 years (ranging from 20 to 60 years). However, 
since most patients attribute proctologic symptoms to haemorrhoidal disease 
without referring to a specialist, abscesses and fistulas real incidence is unknown.
As previously said, both anal abscesses and fistulas usually originate from 
obstructed anal crypt glands. Less frequently they can be caused by inflammatory 
bowel disease (mainly Crohn’s disease), infection such as actinomycosis, tubercu-
losis and lymphogranuloma venereum, human immunodeficiency virus, trauma 
(both in case of iatrogenic injuries and foreign rectal bodies), surgery, malignancy 
and irradiation [50, 55].
The commonest onset of a perianal abscess is constant severe pain, usually not 
related to bowel movements, that can be associated to general symptoms such as 
fever or generalised malaise [52]. On the contrary, intermittent perianal pain exac-
erbated by bowel movements and chronic purulent drainage are typical manifesta-
tions of fistulas [56].
On physical examination, abscesses present as erythematous, tender and fluctu-
ant masses; purulent drainage, either from the overlying skin or from the rectum, 
can be present if the abscess has begun to spontaneously drain [52]. On the con-
trary, the presence of an external opening draining pus and a palpable cord leading 
from the detected external orifice to an internal orifice, are the most common 
findings in case of anal fistula [56].
Although collecting the medical history and performing a physical examination 
allow to detect the majority of abscesses and fistulas, sometimes patients may not 
have any physical finding on examination, and further instrumental exams may 
be required. Local examination may result difficult in case of deep abscesses, not 
appreciable on external examination nor by digitorectal examination, and in case 
of incomplete or blind-ended fistulas, lacking of the external orifice. Moreover, 
symptoms of both conditions may overlap with the clinical manifestations of other 
proctologic diseases. In these cases and in case of complex or recurrent fistulas, 
imaging is necessary [57, 58]. The most commonly performed imaging studies are 
magnetic resonance imaging (MRI), which is the gold standard imaging technique, 
and endosonography (EUS), having a specificity of 69% and 43% respectively, 
and the same sensitivity of 87% [58–60]. Instrumental investigation gives impor-
tant information about abscess localisation, fistula anatomy and integrity of the 
sphincter muscles, allowing to establish the proper treatment.
In case of anal abscesses, the required treatment is always a prompt drain-
age, considering that all undrained abscess can expand toward adjacent spaces or 
progress to a systemic infection [56, 57]. Surgical approach may vary depending on 
imaging findings, that allow to classify an abscess as follow:
• Simple anorectal abscess, or perianal abscess
• Complex anorectal abscess, including:
11
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 ○ Ischiorectal abscess, which extended through the external anal sphincter into 
the ischiorectal space
 ○ Intersphincteric abscess, located in the intersphincteric groove
 ○ Supraelevator abscess, reaching the supralevator space and originating from 
cryptoglandular infection or pelvic inflammatory processes
 ○ Horseshoe abscess, rising posteriorly to the anal canal and extending to the 
ischiorectal space
According to this classification, perianal abscesses treatment can be safely per-
formed in an outpatient setting, while in case of complex, large or deep abscesses, 
drainage should be performed in the operating room, under general anaesthesia, 
sedation or local anaesthesia [61].
Anorectal fistula management is quite more difficult, considering the chosen 
surgical treatment depends on the relation between the fistula tract and the exter-
nal anal sphincter, and on the amount of the sphincter complex involved with the 
fistulous tract. According to Parks’ classification, firstly described in 1976, four 
different types of anal fistula can be identified based on the relationship between 
the primary track and the sphincter [62]:
• Parks type 1, intersphincteric fistula (45%), which extend between internal 
and external sphincter
• Parks type 2, transsphinteric fistula (30%), passing through internal and 
external sphincter, reaching perineum
• Parks type 3, sovrasphincteric fistula (20%), which encircles both internal and 
external sphincters, reaching the ischiorectal fossa
• Parks type 4, extrasphincteric fistula (3%), which encompasses the entire 
sphincter apparatus, including the levators, reaching the skin overlying the 
buttock; this fistula usually does not come from a cryptoglandular abscess
• Superficial, not involving any sphincter muscle (not included in the original 
Parks classification)
A fistula can also be categorised as simple or complex. The former includes 
those with an intersphincteric or low transsphincteric track that involves less 
than 30% of the sphincter complex. A fistula in the presence of inflammatory 
bowel disease, malignancy, incontinence, chronic diarrhoea or previous irradia-
tion should be considered complex as well as those with an anterior track in a 
female patient [63]. In some complex cases, a staged surgical procedure will be 
required.
Since perianal infection sequelae range from minor pain and social embarrass-
ment due to smelly purulent drainage, to life-threatening sepsis, once a diagnosis 
is established, surgery is the mainstay of the treatment, aiming to resolve local 





Abscess incision and drainage is a procedure that can be performed either under 
local anaesthesia, in an ambulatory setting, whenever the pus collection is small 
and superficial, either under general anaesthesia, sedation or local anaesthesia in 
the operating room, in case of more complex, larger or deeper abscesses [56, 57]. In 
these cases an office-based treatment can be performed only in referral centres if 
carried out by expert surgeons.
Incision should be performed as close as possible to the anal verge minimis-
ing the length of a potential fistula while still providing adequate drainage 
of the collection. As 30–70% of abscesses present with a concomitant fistula, 
surgeons question whether to perform or not a primary fistulotomy with the 
abscess drainage [64–67]. Data regarding this argument show primary fistu-
lotomy reduces the risk of recurrence and persistence of the disease, but increase 
sphincter damage risk even leading to faecal incontinence [56, 57, 68]. Thus, 
primary fistulotomy is recommended only in case of simple anal fistula or high 
recurrence risk.
While perianal abscesses (simple abscesses) may be treated in an ambulatory 
setting, complex abscesses usually require an operating theatre, except for small 
intersphincteric abscesses, that can be managed without requiring an exploration 
under anaesthesia (EUA).
Regardless of the surgical setting, a course of empiric antibiotics is strongly 
recommended for all patients who went through incision and drainage of an 
anorectal abscess, in order to reduce the rate of fistula formation. Recommended 
drugs are amoxicillin-clavulanate or a combination of ciprofloxacin and metro-
nidazole, administered for a four- to five-day course [69]. However, even if this 
treatment reduces fistula recurrence rate, it does not affect abscess recurrence 
rate [70].
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6.2 Setonage and fistulotomy
Setonage and fistulotomy represent the gold standard for the treatment of ano-
rectal fistulas and can be performed both in an outpatient setting and in an operat-
ing room, depending on fistula anatomical features. The placement of a seton can 
be considered when the internal opening is identifiable. Fistulotomy can be carried 
out with a simultaneous drainage of the abscess in case of a simple fistula, or can be 
performed as a second stage procedure 4–8 weeks after drainage [56, 57].
Fistulotomy is performed with the patient laying on a left lateral position. After 
a probe is inserted into the external opening and gently passed along the fistula 
tract to the internal opening, an incision is made over the entire length of the fistula 
using the probe as a guide. The tract is then gently curetted and is left opened to 
heal for second-intention healing or marsupialised to promote healing, depending 
on surgeons preference. The most critical step in this procedure is to identify and 
curette the internal opening to reduce the risk of recurrence, since concomitant 
induration due to inflammation may obscure the internal opening. Hydrogen perox-
ide injected through the external orifice may help to identify the internal opening 
[66], while overzealous attempts with a fistula probe should be discouraged as they 
can cause iatrogenic damage [71].
The most concerning potential complication of a fistulotomy is incontinence 
(either to solid faeces or liquid faeces or gas) from procedure-related damageto 
the external anal sphincter. The reported rates of incontinence are highly vari-
able, ranging from 0 to 82% [72, 73], with an increased risk if the fistulotomy is 
performed at the time of the drainage of an acute abscess [74]. Nevertheless, when 
fistulotomy is used forsimple anal fistulas in properly selected patients, the risk of 
faecal incontinence is minimal or none [75, 76].
This treatment is indicated to manage simple fistulas, thus superficial fistulas, 
intersphincteric fistulas and low transsphincteric fistulas, involving less than 30% of 
the sphincter complex. For these fistula it is an effective treatment with a high suc-
cess rate ranging from 79 to 100% [77–79] and low recurrence rates [66, 72, 80, 81].
In females and in patients with preoperative impairment of continence, a high 
or recurrent fistula, previous fistula surgery or Crohn’s disease, any division of the 
Outpatient Care
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sphincter should be undertaken with caution and by an experienced surgeon [82]. 
The location of the internal opening per se, whether high or low in the anal canal, 
should not be used as a guide to “safe fistulotomy”.
As fistulotomy, also the insertion of a seton through the fistula track is per-
formed with the patient laying on a left lateral position and requires fistula track 
probing. Once the seton lays through the fistula track it can be used in different 
ways. A loose seton purpose is to facilitate drainage preventing an acute exacerba-
tion of abscess formation and to allow healing of any secondary tracts, allowing 
local assessment some weeks later [57, 83]. A cutting seton purpose is to allow 
a gradual division of the sphincter, thank to a progressive tightening [57, 84]. 
Recently reported data of patients undergoing fistulotomy with a cutting seton 
tightened every 6–8 weeks, reported healing rates over 90% with only minor 
disturbances in anal sphincter function in 4% of patients [85–87].
Complex fistula treatment, including ligation of intersphincteric fistula tract 
(LIFT) [88, 89], advancement flap [90, 91], diversion, proctectomy and modified 
Haley procedure, cannot be performed in an office-based setting.
7. Perianal Crohn’s disease
Crohn’s disease (CD) is an idiopathic, incurable chronic inflammatory disease of 
the GI tract [92–95], associated in more than 30% of cases to symptoms of perianal 
disease (PAD) [96–98]. The risk of developing PAD is consistent with the time from 
the diagnosis of CD, from 20% after ten years and up to 30% after twenty years. 
However, PAD is far more common in patients with colon (41%) and rectum (90%) 
localization and less in patients with ileal disease (12%) [99–102]. Early diagnosis 
and correct treatment are crucial to allow patients to promptly start medical treat-
ments with antitumor necrosis factor (tnf) which is considered the cornerstone of 
treatment, offering the best long-term control of PAD [103–116].
The gold standard to assess symptomatic perianal disease (PAD) in CD patients is 
the exploration of the anal canal and distal rectum under anaesthesia (EUA) [117–122]. 
EUA usually allows a correct diagnosis of fistulous tracts, a classification of the fistula, 
and an appropriate treatment of the PAD at the same time. In tertiary centres, PAD 
treatment can be performed also in an outpatient setting by expert surgeons. Whether 
to perform an EUA or an outpatient exploration (OE) depends on the anatomy, the 
type of fistula, and finally, the surgeon’s expertise [123–129]. Moreover, active proctitis 
control must be achieved whenever possible prior to any surgical treatment. Treatment 
strategy and procedures are different in an acute or in an elective setting; in acute 
management, the main aim is sepsis control: incision and drainage of every abscess 
are strongly advised, while placement of a loose seton should be considered only if 
the fistulous tract can be promptly and easily identified [120]. In an elective setting, 
an exploration of the anal canal and distal rectum under anaesthesia is recommended 
and, in case of complex fistula, even in the presence of proctitis, a loose, draining seton 
could be passed if the internal and external orifices of the fistulous tract are found. A 
fistulotomy or fistulectomy can be safely considered for simple posterior fistulas [133].
Perianal fistulas in CD may be simple or complex according to the American 
Gastroenterological Association (AGA) [130–133]. Simple fistulas have a high heal-
ing rate, while complex fistulas are difficult to treat and show a poor healing rate 
and increased rate of relapse.
The aim of the surgical treatment of PAD in CD patients should be symptoms 
or complication control, allowing patients to pursue a timely medical therapy, in a 
multidisciplinary management. In the presence of a symptomatic perianal fistula, 
an optimal result can be considered to avoid sepsis, allowing for a good drainage 
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before thinking to the complete healing of the fistula and finally preventing the 
recurrence and preserving the continence of the anal sphincter. It is essential to 
ensure timely treatment, because perianal fistulas significantly impair the quality 
of life of the patients, to avoid the potentially disastrous consequences such as those 
of an undrained sepsis or ramification of the fistulous tracts [134–139]. Only the 
patients with symptomatic Crohn’s anal fistula should undergo a surgical treatment. 
The gold standard treatment for symptomatic perianal disease in CD patients is 
conducted during the EUA. Most of the series available in literature refer to day 
surgery or overnight admission. Unfortunately, a timely treatment is not always 
possible and this, as said, may well represent a relevant clinical issue.
According to the Association of Coloproctology of Great Britain and Ireland 
consensus conference on surgical management of fistulating perianal Crohn’s 
disease, experienced surgeons should always try to place a seton when the fistulous 
tract is readily identifiable and this should be possible most of the times in “skilled 
hands”. Compliance of patients to the procedure was high and, from a surgical point 
of view, the OE was nice to perform without difficulties or trouble in all cases.
This procedure should be offered in a high-volume center in which a multidisci-
plinary dedicated team is available. In selected cases, OE may be offered as a “bridge 
to surgery,” able to faster solve critical clinical issues or palliate disabling symptoms 
with low morbidity and discomfort, also allowing patients to continue medical 
therapy. OE can be repeated, if necessary, in different occasion. From an economi-
cal point of view, the OE can definitively save logistics and money. The OE surely is 
a minimally invasive approach, with low morbidity and very low patient stress. OE 
could be a safe and effective procedure that can be proposed to the vast majority of 
patients with Crohn’s fistulas. It is not recommended in nonexperienced hands and 
in high complex or rectovaginal fistulas (Hughes classification 1b, 1d or 2d, and 2e).
8. Anal warts
Anal warts, also known as condyloma acuminata, are growths of tissue localised in 
the area around and inside the anus, usually caused by human papillomavirus (HPV).
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The Human Papilloma Virus (HPV) used to be thought as one of the most common 
sexually transmitted diseases (STds) [140]. The estimated incidence of HPV infection 
is high, with 14 million persons infected annually and 79 million persons with preva-
lent infection [141]. Its family (Papillomaviridae) consists of more than 120 viruses 
presenting a tropism toward either the cutaneous or mucosa epithelium, however the 
vast majority (90%) of anal warts are caused only by two low-risk HPV subtypes: 6 
and 11 [142]. Further HPV-associated diseases include other mucocutaneous warts as 
well as cervical, anal, vaginal, vulvar, penile, and oropharyn-geal cancers.
Anogenital warts (AGWs) diagnosis is most often based on their clinical appear-
ance, and tests for the presence of HPV are not recommended for their diagnosis. 
They firstly appear as tiny spots or growths, whose dimensions may rapidly increase 
even covering the anal area. Usually, they do not cause any pain or discomfort. Some 
patients may experience itching, bleeding, mucus discharge, or a feeling of a lump 
or mass in the area. Histologic examination of biopsy specimens can be performed 
to rule out intraepithelial or invasive squamous cell carcinomas (SCCs), which can 
coexist with or appear similar to AGWs.
Therapeutic options for the treatment of anal warts range from topical medical 
therapies to surgery. Many treatment modalities for anal warts are primarily focused 
on destroying or removing the warts locally rather than eliminating the infection 
[143]. There are several factors that influence the choice of treatment modality, 
such as location of the warts (all intra-anal or rectal warts should be managed by a 
specialist), number of lesions, patient’s ability to apply prescribed creams or gels, 
patient’s preference, cost of the treatment and patient’s immunosuppression status.
Treatment plans can be classified either as patient self-administered modali-
ties (for warts locat-ed on the perianal skin only) or treatment administered by a 
professional (for lesions in an intra-anal or rectal mucosa location).
Patient-applied treatment consists of topical medications includig podophyllin, 
trichloroacetic acid, bichloroacetic acid, sintecatechins and imiquimod or 5-fluoro-
uracil that can be safely applied at home. Recurrence rates after topical medications 
widely range from 6.5–55%, being sinecatechins the most effective treatment with 
eradication rate similar to other topically applied treatments, but the lowest recur-
rence rate [144–146]. Moreover, patient-applied treatment side effects, which are 
similar for all the ointments and include redness, irritation or a burning sensation, 
are reported by only 1 out of 3 treated patients.
Following the center for disease control and prevention recommendations, 
treatments administered by a medical provider include 80–90% trichloroacetic 
acid (TCA) application, cryotherapy with liquid nitrogen or surgery/electrosur-
gery [147]. Just as for haemorrhoids, all of the procedures can be offered in an 
outpatient setting only to patients having small perianal warts, once the conser-
vative treatment fails. Larger lesions require surgery performed in an operating 
theatre.
TCA has an erosive and chemically destructive activity; its application on AGWs 
burns and cauterises skin lesions. Its destructive activity may extend to nearby 
healthy skin, thus care must be taken during application. It is not recommended for 
intra-anal use. Success rates are satisfactory, ranging from 70 to 81% [148, 149], but 
recurrence rate is high: 36% [149].
Cryotherapy seems to be the best therapeutic. The treatment consist of freezing 
lesions using a liquid nitrogen cooling probe, which results in necrosis and further 
clearance of destroyed tissue. Complications can include the destruction of healthy 
skin, and ulcers or scar formation. Even if eradication and recurrence rates are 
similar to TCA (86% and 39% respectively) [148, 149], cryotherapy is usually pre-
ferred because it is cost effective, minimally invasive, painless and can be applied to 
intra-anal warts.
17
Ambulatory Surgery for Perianal Disease
DOI: http://dx.doi.org/10.5772/intechopen.97119
Surgical excision is the oldest approach, but for patients suffering from a giant 
condyloma (Buschke-Loewenstein tumour) it may be the treatment of choice [150, 
151]. A more contemporary surgical approach, electrosurgery, is a very effective 
technique with a clearance rate of 94% [152] but can be painful and requires local or 
intravenous anaesthesia, thus cannot be performed in an ambulatory setting.
Whether specialist–applied treatment is performed in the operating room or 
in an ambulatory setting, it usually has satisfactory eradication rates, but also high 
recurrence rate, ranging from 25 to 40% [152] discouraging clinical use. Actually, 
all of these modalities are targeted to remove warts locally and do not destroy all 
the very small or subclinical lesions in the surrounding healthy-looking skin, thus 
increasing the risk of recurrence.
9. Skin tags
Anal skin tags are perianal skin excesses, resulting from repeated scarring, 
just as in case of healing from anal fissure or thrombosed external haemorrhoids, 
exacerbated by excess cleaning or rubbing. Affected patients are bothered by the 
skin excess, but usually do not complain about pain or bleeding.
Treatment includes the management of both the underlying cause and the skin 
lesion. The latter consists of skin tags excision easily performed as an office-based 
treatment, that should always follow the resolution of the underlying ano-rectal 
disease, to minimise the risk of recurrence.
Conflict of interest




Andrea Divizia1* and Giuseppe S. Sica2
1 Department of Surgical Science, Tor Vergata University, Rome, Italy
2 Gastro-Intestinal Surgery, Head Department of Surgical Science Tor Vergata 
University, Rome, Italy
*Address all correspondence to: andreadivizia@live.it
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
19
Ambulatory Surgery for Perianal Disease
DOI: http://dx.doi.org/10.5772/intechopen.97119
References
[1] Sobrado CW. Outpatient 
surgical proctology--past, present 
and future. Arq Gastroenterol. 
2005;42(3):133-135. doi: 10.1590/
s0004-28032005000300001
[2] Sibio S, Di Giorgio A, 
Campanelli M, Di Carlo S, Divizia A, 
Fiorani C, Scaramuzzo R, Arcudi C, 
Del Vecchio Blanco G, Biancone L, 
Sica G. Ambulatory Surgery for Perianal 
Crohn's Disease: Study of Feasibility. 
Gastroenterol Res Pract. 2018:5249087. 
doi: 10.1155/2018/5249087
[3] Ternent CA, Fleming F, Welton ML, 
Buie WD, Steele S, Rafferty J; American 
Society of Colon and Rectal Surgeons. 
Clinical Practice Guideline for 
Ambulatory Anorectal Surgery. Dis 
Colon rectum. 2015;58(10):915-922. doi: 
10.1097/DCR.0000000000000451
[4] Gebbensleben O, Hilger Y, Rohde H. 
Patients' views of medical positioning 
for proctologic examination. Clin Exp 
Gastroenterol. 2009;2:133-138. doi: 
10.2147/ceg.s8429
[5] Lee JH. Anesthesia for ambulatory 
surgery. Korean J Anesthesiol. 2017; 
70(4):398-406. doi: 10.4097/kjae. 
2017.70.4.398
[6] Kehlet H. Postoperative opioid 
sparing to hasten recovery: what 
are the issues? Anesthesiology. 
2005;102(6):1083-1085. doi: 10.1097/ 
00000542-200506000-00004
[7] White PF. The changing role of 
non-opioid analgesic techniques in the 
management of postoperative pain. 
Anesth Analg. 2005;101(5 Suppl):S5-22. 
doi: 10.1213/01.ane.0000177099.28914.a7
[8] Tejirian T, Abbas MA. Sitz bath: 
where is the evidence? Scientific basis 
of a common practice. Dis Colon rectum. 
2005;48(12):2336-2340. doi: 10.1007/
s10350-005-0085-x
[9] Lohsiriwat V. Treatment of 
hemorrhoids: A coloproctologist's view. 
World J Gastroenterol. 2015;21(31):9245-
9252. doi: 10.3748/wjg.v21.i31.9245
[10] Jacobs D. Clinical practice. Hemorr-
hoids. N Engl J Med. 2014;371(10):944-
951. doi: 10.1056/NEJMcp1204188
[11] van Tol RR, Kimman ML, 
Melenhorst J, Stassen LPS, Dirksen CD, 
Breukink SO; Members of the Steering 
Group. European Society of 
Coloproctology Core Outcome Set  
for haemorrhoidal disease: an 
international Delphi study among 
healthcare professionals. Colorectal 
Dis. 2019;21(5):570-580. doi: 10.1111/
codi.14553
[12] van Tol RR, Kleijnen J, Watson AJM, 
Jongen J, Altomare DF, Qvist N, 
Higuero T, Muris JWM, Breukink SO. 
European Society of ColoProctology: 
guideline for haemorrhoidal disease. 
Colorectal Dis. 2020;22(6):650-662. doi: 
10.1111/codi.14975
[13] Rho M, Guida AM, Materazzo M,  
Don CP, Gazia C, Ivanikhin AM,  
Tognoni V, Venditti D. Ligasure 
Hemorrhoidectomy: Updates on 
Complications after an 18-Year 
Experience. Rev Recent Clin Trials. 
2020. doi: 10.2174/157488711599920
1006201926
[14] Gallo G, Martellucci J, Sturiale A,  
Clerico G, Milito G, Marino F, 
Cocorullo G, Giordano P, Mistrangelo M, 
Trompetto M. Consensus statement of 
the Italian society of colorectal surgery 
(SICCR): management and treatment of 
hemorrhoidal disease. Tech Coloproctol. 
2020;24(2):145-164. doi: 10.1007/
s10151-020-02149-1
[15] Gallo G., Sacco R., Sammarco G. 
(2018) Epidemiology of Hemorrhoidal 
Disease. In: Ratto C., Parello A., Litta F. 





[16] Riss S, Weiser FA, Schwameis K,  
Riss T, Mittlböck M, Steiner G, Stift A.  
The prevalence of hemorrhoids in  
adults. Int J Colorectal Dis. 2012; 
27(2):215-220. doi: 10.1007/
s00384-011-1316-3
[17] Lohsiriwat V. Hemorrhoids: from 
basic pathophysiology to clinical 
management. World J Gastroenterol. 
2012;18(17):2009-17. doi: 10.3748/wjg.
v18.i17.2009
[18] Trompetto M, Clerico G, 
Cocorullo GF, Giordano P, Marino F, 
Martellucci J, Milito G, Mistrangelo M, 
Ratto C. Evaluation and management of 
hemorrhoids: Italian society of colorectal 
surgery (SICCR) consensus statement. 
Tech Coloproctol. 2015;19(10):567-575. 
doi: 10.1007/s10151-015-1371-9
[19] Gralnek IM, Ron-Tal Fisher O,  
Holub JL, Eisen GM. The role of 
colonoscopy in evaluating hematochezia: 
a population-based study in a large 
consortium of endoscopy practices. 
Gastrointest Endosc. 2013;77(3):410-418. 
doi: 10.1016/j.gie.2012.10.025
[20] Newman J, Fitzgerald JE, 
Gupta S, von Roon AC, Sigurdsson HH, 
Allen-Mersh TG. Outcome predictors 
in acute surgical admissions for lower 
gastrointestinal bleeding. Colorectal 
Dis. 2012;14(8):1020-1026. doi: 
10.1111/j.1463-1318.2011.02824.x
[21] Goligher JC, Leacock AG, Brossy JJ. 
The surgical anatomy of the anal canal. 
Br J Surg. 1955;43(177):51-61. doi: 
10.1002/bjs.18004317707
[22] Davis BR, Lee-Kong SA, Migaly J, 
Feingold DL, Steele SR. The American 
Society of Colon and Rectal Surgeons 
Clinical Practice Guidelines for the 
Management of Hemorrhoids. Dis 
Colon rectum. 2018;61(3):284-292. doi: 
10.1097/DCR.0000000000001030
[23] Marques CF, Nahas SC, Nahas CS, 
Sobrado CW Jr, Habr-Gama A, Kiss DR. 
Early results of the treatment of internal 
hemorrhoid disease by infrared 
coagulation and elastic banding: a 
prospective randomized cross-over trial. 
Tech Coloproctol. 2006;10(4):312-317. 
doi: 10.1007/s10151-006-0299-5
[24] Shanmugam V, Thaha MA, 
Rabindranath KS, Campbell KL, Steele RJ, 
Loudon MA. Rubber band ligation 
versus excisional haemorrhoidectomy 
for haemorrhoids. Cochrane Database 
Syst Rev. 2005;(3):CD005034. doi: 
10.1002/14651858.CD005034
[25] Nelson RS, Ewing BM,  
Ternent C, Shashidharan M, 
Blatchford GJ, Thorson AG. Risk of 
late bleeding following hemorrhoidal 
banding in patients on antithrombotic 
prophylaxis. Am J Surg. 2008;196(6):994-
999; discussion 999. doi: 10.1016/j.
amjsurg.2008.07.036
[26] Buchmann P, Seefeld U. Rubber 
band ligation for piles can be disastrous 
in HIV-positive patients. Int J Colorectal 
Dis. 1989;4(1):57-58. doi: 10.1007/
BF01648552
[27] Wehrmann T, Riphaus A, 
Feinstein J, Stergiou N. Hemorrhoidal 
elastic band ligation with flexible 
videoendoscopes: a prospective, 
randomized comparison with the 
conventional technique that uses rigid 
proctoscopes. Gastrointest Endosc. 
2004;60(2):191-195. doi: 10.1016/
s0016-5107(04)01551-2
[28] Ramzisham AR, Sagap I, Nadeson S,  
Ali IM, Hasni MJ. Prospective 
randomized clinical trial on suction 
elastic band ligator versus forceps ligator 
in the treatment of haemorrhoids. Asian 
J Surg. 2005;28(4):241-245. doi: 10.1016/
S1015-9584(09)60353-5
[29] Khubchandani IT. A randomized 
comparison of single and multiple 
rubber band ligations. Dis Colon rectum. 
21




[30] Iyer VS, Shrier I, Gordon PH. Long-
term outcome of rubber band ligation 
for symptomatic primary and recurrent 
internal hemorrhoids. Dis Colon rectum. 
2004;47(8):1364-1370. doi: 10.1007/
s10350-004-0591-2
[31] Beattie GC, Rao MM, Campbell WJ. 
Secondary haemorrhage after rubber 
band ligation of haemorrhoids in 
patients taking clopidogrel--a cautionary 
note. Ulster Med J. 2004;73(2):139-41. 
PMCID: PMC2475464
[32] Chau NG, Bhatia S, Raman M. 
Pylephlebitis and pyogenic liver abscesses: 
a complication of hemorrhoidal banding. 
Can J Gastroenterol. 2007;21(9):601-603. 
doi: 10.1155/2007/106946
[33] Tejirian T, Abbas MA. Bacterial 
endocarditis following rubber band 
ligation in a patient with a ventricular 
septal defect: report of a case and 
guideline analysis. Dis Colon rectum. 
2006;49(12):1931-1933. doi: 10.1007/
s10350-006-0769-x
[34] McCloud JM, Jameson JS, Scott AN. 
Life-threatening sepsis following 
treatment for haemorrhoids: a 
systematic review. Colorectal 
Dis. 2006;8(9):748-755. doi: 
10.1111/j.1463-1318.2006.01028.x
[35] Cocorullo G, Tutino R, Falco N, 
Licari L, Orlando G, Fontana T, 
Raspanti C, Salamone G, Scerrino G, 
Gallo G, Trompetto M, Gulotta G. 
The non-surgical management for 
hemorrhoidal disease. A systematic 
review. G Chir. 2017;38(1):5-14. doi: 
10.11138/gchir/2017.38.1.005
[36] Brown SR, Tiernan JP, Watson AJM, 
Biggs K, Shephard N, Wailoo AJ, 
Bradburn M, Alshreef A, Hind D; 
HubBLe Study team. Haemorrhoidal 
artery ligation versus rubber 
band ligation for the management 
of symptomatic second-degree 
and third-degree haemorrhoids 
(HubBLe): a multicentre, open-label, 
randomised controlled trial. Lancet. 
2016;388(10042):356-364. doi: 10.1016/
S0140-6736(16)30584-0
[37] Moser KH, Mosch C, Walgenbach M, 
Bussen DG, Kirsch J, Joos AK, Gliem P, 
Sauerland S. Efficacy and safety of 
sclerotherapy with polidocanol foam in 
comparison with fluid sclerosant in the 
treatment of first-grade haemorrhoidal 
disease: a randomised, controlled, 
single-blind, multicentre trial. Int J 
Colorectal Dis. 2013;28(10):1439-1447. 
doi: 10.1007/s00384-013-1729-2
[38] Yano T, Asano M, Tanaka S, 
Oda N, Matsuda Y. Prospective study 
comparing the new sclerotherapy 
and hemorrhoidectomy in terms of 
therapeutic outcomes at 4 years after the 
treatment. Surg Today. 2014;44(3):449-
453. doi: 10.1007/s00595-013-0564-y
[39] Tsunoda A, Nakagi M, Kano N, 
Mizutani M, Yamaguchi K. Serum 
aluminum levels in dialysis patients 
after sclerotherapy of internal 
hemorrhoids with aluminum potassium 
sulfate and tannic acid. Surg Today. 
2014;44(12):2314-2317. doi: 10.1007/
s00595-014-0914-4
[40] Schulte T, Fändrich F, Kahlke V. 
Life-threatening rectal necrosis after 
injection sclerotherapy for haemo-
rrhoids. Int J Colorectal Dis. 2008;23(7): 
725-726. doi: 10.1007/s00384-007- 
0402-z
[41] MacRae HM, McLeod RS. Compa-
rison of hemorrhoidal treatments: a  
meta-analysis. Can J Surg. 1997;40(1): 
14-17. doi: 10.1007/BF02048023
[42] Gupta PJ. Infrared coagulation 
versus rubber band ligation in early 





[43] Dimitroulopoulos D, Tsamakidis K,  
Xinopoulos D, Karaitianos I, 
Fotopoulou A, Paraskevas E. Prospective, 
randomized, controlled, observer-
blinded trial of combined infrared 
photocoagulation and micronized 
purified flavonoid fraction versus each 
alone for the treatment of hemorrhoidal 
disease. Clin Ther. 2005;27(6):746-754. 
doi: 10.1016/j.clinthera.2005.06.016
[44] Lohsiriwat V. Anorectal emergencies. 
World J Gastroenterol. 2016;22(26):5867-
5878. doi: 10.3748/wjg.v22.i26.5867
[45] Aigner F, Gruber H, Conrad F,  
Eder J, Wedel T, Zelger B, Engelhardt V,  
Lametschwandtner A, Wienert V,  
Böhler U, Margreiter R, Fritsch H.  
Revised morphology and hemo-
dynamics of the anorectal vascular 
plexus: impact on the course of 
hemorrhoidal disease. Int J Colorectal 
Dis. 2009;24(1):105-113. doi: 10.1007/
s00384-008-0572-3
[46] Grosz CR. A surgical treatment of 
thrombosed external hemorrhoids. Dis 
Colon rectum. 1990;33(3):249-250. doi: 
10.1007/BF02134191
[47] Rivadeneira DE, Steele SR, 
Ternent C, Chalasani S, Buie WD, 
Rafferty JL; Standards Practice Task 
Force of The American Society of 
Colon and Rectal Surgeons. Practice 
parameters for the management of 
hemorrhoids (revised 2010). Dis Colon 
rectum. 2011;54(9):1059-1064. doi: 
10.1097/DCR.0b013e318225513d
[48] Greenspon J, Williams SB, 
Young HA, Orkin BA. Thrombosed 
external hemorrhoids: outcome after 
conservative or surgical management. 
Dis Colon rectum. 2004;47(9):1493-1498. 
doi: 10.1007/s10350-004-0607-y.
[49] Jongen J, Bach S, Stübinger SH, 
Bock JU. Excision of thrombosed 
external hemorrhoid under local 
anesthesia: a retrospective evaluation 
of 340 patients. Dis Colon rectum. 
2003;46(9):1226-1231. doi: 10.1007/
s10350-004-6719-6
[50] PARKS AG. Pathogenesis and 
treatment of fistuila-in-ano. Br Med J. 
1961;1(5224):463-469. doi: 10.1136/
bmj.1.5224.463
[51] Gosselink MP, van Onkelen RS, 
Schouten WR. The cryptoglandular 
theory revisited. Colorectal Dis. 
2015;17(12):1041-1043. doi: 10.1111/
codi.13161
[52] Abcarian H. Anorectal infection: 
abscess-fistula. Clin Colon Rectal Surg. 
2011;24(1):14-21. doi: 10.1055/s-0031- 
1272819
[53] Sneider EB, Maykel JA. Anal abscess 
and fistula. Gastroenterol Clin North 
Am. 2013;42(4):773-784. doi: 10.1016/j.
gtc.2013.08.003
[54] Zanotti C, Martinez-Puente C, 
Pascual I, Pascual M, Herreros D, 
García-Olmo D. An assessment of the 
incidence of fistula-in-ano in four 
countries of the European Union. Int J 
Colorectal Dis. 2007;22(12):1459-1462. 
doi: 10.1007/s00384-007-0334-7
[55] Parés D. Pathogenesis and treatment 
of fistula in ano. Br J Surg. 2011;98(1):2-
3. doi: 10.1002/bjs.7341
[56] Vogel JD, Johnson EK, Morris AM, 
Paquette IM, Saclarides TJ, Feingold DL, 
Steele SR. Clinical Practice Guideline 
for the Management of Anorectal 
Abscess, Fistula-in-Ano, and 
Rectovaginal Fistula. Dis Colon rectum. 
2016;59(12):1117-1133. doi: 10.1097/
DCR.0000000000000733.
[57] Amato A, Bottini C, De Nardi P, 
Giamundo P, Lauretta A, Realis Luc A, 
Tegon G, Nicholls RJ; Italian society 
of colorectal surgery. Evaluation and 
management of perianal abscess and 
anal fistula: a consensus statement 
developed by the Italian Society of 
Colorectal Surgery (SICCR). Tech 
23
Ambulatory Surgery for Perianal Disease
DOI: http://dx.doi.org/10.5772/intechopen.97119
Coloproctol. 2015;19(10):595-606. doi: 
10.1007/s10151-015-1365-7
[58] Siddiqui MR, Ashrafian H, 
Tozer P, Daulatzai N, Burling D, Hart A, 
Athanasiou T, Phillips RK. A diagnostic 
accuracy meta-analysis of endoanal 
ultrasound and MRI for perianal 
fistula assessment. Dis Colon rectum. 
2012;55(5):576-585. doi: 10.1097/
DCR.0b013e318249d26c
[59] Buchanan GN, Halligan S, Bartram CI, 
Williams AB, Tarroni D, Cohen CR. 
Clinical examination, endosonography, 
and MR imaging in preoperative 
assessment of fistula in ano: comparison 
with outcome-based reference standard. 
Radiology. 2004;233(3):674-681. doi: 
10.1148/radiol.2333031724
[60] Pomerri F, Dodi G, Pintacuda G,  
Amadio L, Muzzio PC. Anal 
endosonography and fistulography 
for fistula-in-ano. Radiol Med. 
2010;115(5):771-783. doi: 10.1007/
s11547-010-0524-1
[61] Rizzo JA, Naig AL, Johnson EK. 
Anorectal abscess and fistula-in-ano: 
evidence-based management. Surg Clin 
North Am. 2010;90(1):45-68, Table of 
Contents. doi: 10.1016/j.suc.2009.10.001
[62] Parks AG, Gordon PH, Hardcastle JD. 
A classification of fistula-in-ano. Br 
J Surg. 1976;63(1):1-12. doi: 10.1002/
bjs.1800630102
[63] Fazio VW. Complex anal fistulae. 
Gastroenterol Clin North Am. 
1987;16(1):93-114. PMID: 3298058
[64] Schouten WR, van Vroonhoven TJ. 
Treatment of anorectal abscess with or 
without primary fistulectomy. Results 
of a prospective randomized trial. Dis 
Colon rectum. 1991;34(1):60-63. doi: 
10.1007/BF02050209
[65] Tang CL, Chew SP, Seow-Choen F.  
Prospective randomized trial of 
drainage alone vs. drainage and 
fistulotomy for acute perianal abscesses 
with proven internal opening. Dis Colon 
rectum. 1996;39(12):1415-1417. doi: 
10.1007/BF02054531
[66] Ho YH, Tan M, Chui CH, Leong A, 
Eu KW, Seow-Choen F. Randomized 
controlled trial of primary fistulotomy 
with drainage alone for perianal abscesses. 
Dis Colon rectum. 1997;40(12):1435-1438. 
doi: 10.1007/BF02070708
[67] Oliver I, Lacueva FJ, Pérez 
Vicente F, Arroyo A, Ferrer R, Cansado P, 
Candela F, Calpena R. Randomized 
clinical trial comparing simple drainage 
of anorectal abscess with and without 
fistula track treatment. Int J Colorectal 
Dis. 2003;18(2):107-110. doi: 10.1007/
s00384-002-0429-0
[68] Malik AI, Nelson RL, Tou S. Incision 
and drainage of perianal abscess 
with or without treatment of anal 
fistula. Cochrane Database Syst 
Rev. 2010;(7):CD006827. doi: 
10.1002/14651858.CD006827.pub2
[69] Sawyer RG, Claridge JA, Nathens AB, 
Rotstein OD, Duane TM, Evans HL, 
Cook CH, O'Neill PJ, Mazuski JE, 
Askari R, Wilson MA, Napolitano LM, 
Namias N, Miller PR, Dellinger EP, 
Watson CM, Coimbra R, Dent DL, 
Lowry SF, Cocanour CS, West MA, 
Banton KL, Cheadle WG, Lipsett PA, 
Guidry CA, Popovsky K; STOP-IT 
Trial Investigators. Trial of short-
course antimicrobial therapy for 
intraabdominal infection. N Engl J Med. 
2015;372(21):1996-2005. doi: 10.1056/
NEJMoa1411162
[70] Mocanu V, Dang JT, Ladak F, 
Tian C, Wang H, Birch DW, Karmali S. 
Antibiotic use in prevention of anal 
fistulas following incision and drainage 
of anorectal abscesses: A systematic 





[71] de Groof EJ, Cabral VN, Buskens CJ, 
Morton DG, Hahnloser D, Bemelman 
WA; research committee of the 
European Society of Coloproctology. 
Systematic review of evidence and 
consensus on perianal fistula: an analysis 
of national and international guidelines. 
Colorectal Dis. 2016;18(4):O119–O134. 
doi: 10.1111/codi.13286
[72] Hammond TM, Knowles CH, 
Porrett T, Lunniss PJ. The Snug Seton: 
short and medium term results of slow 
fistulotomy for idiopathic anal fistulae. 
Colorectal Dis. 2006;8(4):328-337. doi: 
10.1111/j.1463-1318.2005.00926.x
[73] Dziki A, Bartos M. Seton 
treatment of anal fistula: experience 
with a new modification. Eur J 
Surg. 1998;164(7):543-548. doi: 
10.1080/110241598750005930
[74] Quah HM, Tang CL, Eu KW, 
Chan SY, Samuel M. Meta-analysis of 
randomized clinical trials comparing 
drainage alone vs primary sphincter-
cutting procedures for anorectal 
abscess-fistula. Int J Colorectal Dis. 
2006;21(6):602-609. doi: 10.1007/
s00384-005-0060-y
[75] Hall JF, Bordeianou L, Hyman N,  
Read T, Bartus C, Schoetz D, 
Marcello PW. Outcomes after operations 
for anal fistula: results of a prospective, 
multicenter, regional study. Dis Colon 
rectum. 2014;57(11):1304-1308. doi: 
10.1097/DCR.0000000000000216
[76] Abramowitz L, Soudan D, 
Souffran M, Bouchard D, Castinel A, 
Suduca JM, Staumont G, Devulder F, 
Pigot F, Ganansia R, Varastet M; Groupe 
de Recherche en Proctologie de la 
Société Nationale Française de Colo-
Proctologie and the Club de Réflexion 
des Cabinets et Groupe d'Hépato-
Gastroentérologie. The outcome of 
fistulotomy for anal fistula at 1 year: a 
prospective multicentre French study. 
Colorectal Dis. 2016;18(3):279-285. doi: 
10.1111/codi.13121
[77] Davies M, Harris D, Lohana P,  
Chandra Sekaran TV, Morgan AR,  
Beynon J, Carr ND. The surgical 
management of fistula-in-ano in a 
specialist colorectal unit. Int J Colorectal 
Dis. 2008;23(9):833-838. doi: 10.1007/
s00384-008-0444-x
[78] Westerterp M, Volkers NA,  
Poolman RW, van Tets WF.  
Anal fistulotomy between Skylla and 
Charybdis. Colorectal Dis. 2003;5(6):549-
551. doi: 10.1046/ 
j.1463-1318.2003.00459.x
[79] Ho KS, Tsang C, Seow-Choen F, 
Ho YH, Tang CL, Heah SM, Eu KW. 
Prospective randomised trial comparing 
ayurvedic cutting seton and fistulotomy 
for low fistula-in-ano. Tech Coloproctol. 
2001;5(3):137-141. doi: 10.1007/
s101510100015
[80] Christensen A, Nilas L,  
Christiansen J. Treatment of trans-
sphincteric anal fistulas by the seton  
technique. Dis Colon rectum. 1986; 
29(7):454-455. doi: 10.1007/BF02561583
[81] van Koperen PJ, Wind J, 
Bemelman WA, Bakx R, Reitsma JB, 
Slors JF. Long-term functional outcome 
and risk factors for recurrence after 
surgical treatment for low and high 
perianal fistulas of cryptoglandular 
origin. Dis Colon rectum. 2008;51(10): 
1475-1481. doi: 10.1007/s10350- 
008-9354-9
[82] Jordán J, Roig JV, García-Armengol J, 
García-Granero E, Solana A, 
Lledó S. Risk factors for recurrence and 
incontinence after anal fistula surgery. 
Colorectal Dis. 2010;12(3):254-260. doi: 
10.1111/j.1463-1318.2009.01806.x
[83] Kelly ME, Heneghan HM, 
McDermott FD, Nason GJ, Freeman C, 
Martin ST, Winter DC. The role of loose 
seton in the management of anal fistula: 
a multicenter study of 200 patients. 
Tech Coloproctol. 2014;18(10):915-919. 
doi: 10.1007/s10151-014-1186-0
25
Ambulatory Surgery for Perianal Disease
DOI: http://dx.doi.org/10.5772/intechopen.97119
[84] Williams JG, MacLeod CA, 
Rothenberger DA, Goldberg SM. 
Seton treatment of high anal fistulae. 
Br J Surg. 1991;78(10):1159-1161. doi: 
10.1002/bjs.1800781004
[85] Patton V, Chen CM, Lubowski D. 
Long-term results of the cutting seton 
for high anal fistula. ANZ J Surg. 
2015;85(10):720-727. doi: 10.1111/
ans.13156
[86] Rosen DR, Kaiser AM. Definitive 
seton management for transsphincteric 
fistula-in-ano: harm or charm? 
Colorectal Dis. 2016;18(5):488-495. doi: 
10.1111/codi.13120
[87] Ritchie RD, Sackier JM, Hodde JP. 
Incontinence rates after cutting seton 
treatment for anal fistula. Colorectal 
Dis. 2009;11(6):564-571. doi: 
10.1111/j.1463-1318.2008.01713.x
[88] Rojanasakul A, Pattanaarun J, 
Sahakitrungruang C, Tantiphlachiva K. 
Total anal sphincter saving technique 
for fistula-in-ano; the ligation of 
intersphincteric fistula tract. J Med 
Assoc Thai. 2007;90(3):581-586
[89] Shanwani A, Nor AM, Amri N. 
Ligation of the intersphincteric fistula 
tract (LIFT): a sphincter-saving 
technique for fistula-in-ano. Dis Colon 
rectum. 2010;53(1):39-42. doi: 10.1007/
DCR.0b013e3181c160c4
[90] Yellinek S, Krizzuk D, Moreno 
Djadou T, Lavy D, Wexner SD. 
Endorectal advancement flap for complex 
anal fistula: does flap configuration 
matter? Colorectal Dis. 2019;21(5):581-
587. doi: 10.1111/codi.14564
[91] Podetta M, Scarpa CR, Zufferey G, 
Skala K, Ris F, Roche B, Buchs NC. 
Mucosal advancement flap for recurrent 
complex anal fistula: a repeatable 
procedure. Int J Colorectal Dis. 
2019;34(1):197-200. doi: 10.1007/
s00384-018-3155-y
[92] Lightner AL, Vogel JD, 
Carmichael JC, Keller DS, Shah SA, 
Mahadevan U, Kane SV, Paquette IM, 
Steele SR, Feingold DL. The American 
Society of Colon and Rectal Surgeons 
Clinical Practice Guidelines for 
the Surgical Management of 
Crohn's Disease. Dis Colon rectum. 
2020;63(8):1028-1052. doi: 10.1097/
DCR.0000000000001716
[93] Strong SA, Koltun WA, Hyman NH, 
Buie WD; Standards Practice Task 
Force of The American Society of 
Colon and Rectal Surgeons. Practice 
parameters for the surgical management 
of Crohn's disease. Dis Colon rectum. 
2007;50(11):1735-1746. doi: 10.1007/
s10350-007-9012-7
[94] Strong S, Steele SR, Boutrous M, 
Bordineau L, Chun J, Stewart DB, 
Vogel J, Rafferty JF; Clinical Practice 
Guidelines Committee of the 
American Society of Colon and Rectal 
Surgeons. Clinical Practice Guideline 
for the Surgical Management of 
Crohn's Disease. Dis Colon rectum. 
2015;58(11):1021-1036. doi: 10.1097/
DCR.0000000000000450
[95] Petagna L, Antonelli A, Ganini C, 
Bellato V, Campanelli M, Divizia A, 
Efrati C, Franceschilli M, Guida AM, 
Ingallinella S, Montagnese F, Sensi B, 
Siragusa L, Sica GS. Pathophysiology 
of Crohn's disease inflammation and 
recurrence. Biol Direct. 2020;15(1):23. 
doi: 10.1186/s13062-020-00280-5.
[96] Schwartz DA, Loftus EV Jr, 
Tremaine WJ, Panaccione R, Harmsen WS, 
Zinsmeister AR, Sandborn WJ. The 
natural history of fistulizing Crohn's 
disease in Olmsted County, Minnesota. 
Gastroenterology. 2002;122(4):875-880. 
doi: 10.1053/gast.2002.32362
[97] Sica GS, Di Carlo S, Tema G, 
Montagnese F, Del Vecchio Blanco G, 
Fiaschetti V, Maggi G, Biancone L. 
Treatment of peri-anal fistula in Crohn's 





[98] Singh B, McC Mortensen NJ, 
Jewell DP, George B. Perianal Crohn's 
disease. Br J Surg. 2004;91(7):801-814. 
doi: 10.1002/bjs.4613
[99] van der Hagen SJ, Baeten CG, 
Soeters PB, van Gemert WG. Long-
term outcome following mucosal 
advancement flap for high perianal 
fistulas and fistulotomy for low perianal 
fistulas: recurrent perianal fistulas: 
failure of treatment or recurrent 
patient disease? Int J Colorectal Dis. 
2006;21(8):784-790. doi: 10.1007/
s00384-005-0072-7
[100] A. M. Scanu, Fistole perianali 
nella malattia di Crohn iter formativo in 
coloproctologia corso avanzato e update 
in colo proctologia. [Internet] Vercelli, 
2008. Available from: https://www.siccr.
org/wp-content/uploads/2015/08/scanu_
doc.pdf [Accessed: 2008-12-15/17]
[101] Ingallinella S, Campanelli M, 
Antonelli A, Arcudi C, Bellato V, 
Divizia A, Franceschilli M, Petagna L, 
Sensi B, Sibio S, Siragusa L, Sica GS. 
The Role of Active Inflammation 
and Surgical Therapy in Crohn's 
Disease Recurrence. Gastroenterol 
Res Pract. 2020;2020:2845407. doi: 
10.1155/2020/2845407
[102] L. Biancone, S. Onali, E. Calabrese, 
C. Petruzziello, F. Zorzi, G. Condino, 
G.S. Sica, F. Pallone. Non-invasive 
techniques for assessing postoperative 
recurrence in Crohn's disease. Dig Liver 
Dis. 2008;40,( 2):265-270. doi: 10.1016/
S1590-8658(08)60536-8
[103] Lee MJ, Freer C, Adegbola S,  
Elkady S, Parkes M, Hart A, 
Fearnhead NS, Lobo AJ, Brown SR. 
Patients with perianal Crohn's fistulas 
experience delays in accessing anti-
TNF therapy due to slow recognition, 
diagnosis and integration of specialist 
services: lessons learned from three 
referral centres. Colorectal Dis. 
2018;20(9):797-803. doi: 10.1111/
codi.14102
[104] Gold SL, Cohen-Mekelburg S, 
Schneider Y, Steinlauf A. Perianal 
Fistulas in Patients With Crohn's Disease, 
Part 1: Current Medical Management. 
Gastroenterol Hepatol (N Y). 
2018;14(8):470-481. PMID: 30302062
[105] Sica GS, Biancone L. Surgery for 
inflammatory bowel disease in the era 
of laparoscopy. World J Gastroenterol. 
2013;19(16):2445-2448. doi: 10.3748/
wjg.v19.i16.2445
[106] Comparative study of laparoscopic 
vs open gastrectomy in gastric cancer 
management Sica, G.S., Iaculli, E., 
Biancone, L., di Carlo, S., Scaramuzzo, 
R., Fiorani, C., Gentileschi, P., Gaspari, 
A.L. .World Journal of Gastroenterology. 
2011;17(41):4602-4606. doi: 10.3748/
wjg.v17.i41.4602
[107] EuroSurg Collaborative. EuroSurg: 
a new European student-driven research 
network in surgery. Colorectal Dis. 
2016 Feb;18(2):214-215. doi:10.1111/
codi.13260
[108] D'Ugo S, Romano F, Sibio S,  
Bagaglini G, Sensi B, Biancone L, 
Monteleone G, Sica GS. Impact of surgery 
on quality of life in Crohn's disease: 
short- and mid-term follow-up. Updates 
Surg. 2020;72(3):773-780. doi: 10.1007/
s13304-020-00738-1
[109] Divizia A, Sensi B, Sica GS. 
Ambulatory management of perianal 
Crohn's disease during the COVID-19 
pandemic. Colorectal Dis. 2020;22(6): 
645-646. doi: 10.1111/codi.15104
[110] Torres J, Bonovas S,  
Doherty G, Kucharzik T, Gisbert JP, 
 Raine T, Adamina M, Armuzzi A, 
Bachmann O, Bager P, Biancone L, 
Bokemeyer B, Bossuyt P, Burisch J, Collins P, 
El-Hussuna A, Ellul P, Frei-Lanter C, 
Furfaro F, Gingert C, Gionchetti P, 
27
Ambulatory Surgery for Perianal Disease
DOI: http://dx.doi.org/10.5772/intechopen.97119
Gomollon F, González-Lorenzo M, 
Gordon H, Hlavaty T, Juillerat P, 
Katsanos K, Kopylov U, Krustins E, 
Lytras T, Maaser C, Magro F, Marshall JK, 
Myrelid P, Pellino G, Rosa I, Sabino J, 
Savarino E, Spinelli A, Stassen L, Uzzan M, 
Vavricka S, Verstockt B, Warusavitarne J, 
Zmora O, Fiorino G. ECCO Guidelines 
on Therapeutics in Crohn's Disease: 
Medical Treatment. J Crohns Colitis. 
2020;14(1):4-22. doi: 10.1093/
ecco-jcc/jjz180
[111] Franzè E, Monteleone I, Laudisi F,  
Rizzo A, Dinallo V, Di Fusco D,  
Colantoni A, Ortenzi A, Giuffrida P,  
Di Carlo S, Sica GS, Di Sabatino A,  
Monteleone G. Cadherin-11 Is a 
Regulator of Intestinal Fibrosis. J 
Crohns Colitis. 2020;14(3):406-417. doi: 
10.1093/ecco-jcc/jjz147
[112] Franzè E, Dinallo V, Laudisi F, Di 
Grazia A, Di Fusco D, Colantoni A, 
Ortenzi A, Giuffrida P, Di Carlo S, 
Sica GS, Di Sabatino A, Monteleone G. 
Interleukin-34 Stimulates Gut Fibroblasts 
to Produce Collagen Synthesis. J Crohns 
Colitis. 2020;14(10):1436-1445. doi: 
10.1093/ecco-jcc/jjaa073
[113] Franzè E, Di Grazia A, Sica GS, 
Biancone L, Laudisi F, Monteleone G. 
Interleukin-34 Enhances the Tumor 
Promoting Function of Colorectal 
Cancer-Associated Fibroblasts. Cancers 
(Basel). 2020;12(12):3537. doi: 10.3390/
cancers12123537
[114] Franzè, E., Dinallo, V., Rizzo, 
A., Di Giovangiulio, M., Bevivino, 
G., Stolfi, C., Caprioli, F., Colantoni, 
A., Ortenzi, A., Di Grazia, A., Sica, 
G., Sileri, P., Rossi, P., Monteleone, G. 
Interleukin-34 sustains pro-tumorigenic 
signals in colon cancer tissue. 
Oncotarget. 2018;9(3):3432-3445
[115] Interleukin-34 Induces 
Cc-chemokine Ligand 20 in Gut 
Epithelial Cells. Franzè E, Marafini I, 
De Simone V, Monteleone I, Caprioli F, 
Colantoni A,Ortenzi A, Crescenzi F, 
Izzo R, Sica G, Sileri P, Rossi P, Pallone F, 
Monteleone G. J. Crohns Colitis. 2016;10(1):87-
94. doi: 10.1093/ecco-jcc/jjv181
[116] Interleukin-25 production is 
differently regulated by TNF-alpha 
and TGF-beta 1 in the human gut. 
Fina D, Franze E, Rovedatti L, 
Corazza GR, Biancone L, Sileri PP, Sica G, 
MacDonald TT, Pallone F, Di Sabatino A, 
Monteleone G. Mucosal Immunology, 
2011;4(2):239-44 doi: 10.1038/mi.2010.68
[117] Haggett PJ, Moore NR, Shearman JD, 
Travis SP, Jewell DP, Mortensen NJ. Pelvic 
and perineal complications of Crohn's 
disease: assessment using magnetic 
resonance imaging. Gut. 1995;36(3):407-
410. doi: 10.1136/gut.36.3.407
[118] Buchanan GN, Halligan S, Bartram CI, 
Williams AB, Tarroni D, Cohen CR. 
Clinical examination, endosonography, 
and MR imaging in preoperative 
assessment of fistula in ano: comparison 
with outcome-based reference standard. 
Radiology. 2004;233(3):674-681. doi: 
10.1148/radiol.2333031724
[119] Sloots CE, Felt-Bersma RJ, 
Poen AC, Cuesta MA, Meuwissen SG. 
Assessment and classification of 
fistula-in-ano in patients with Crohn's 
disease by hydrogen peroxide enhanced 
transanal ultrasound. Int J Colorectal 
Dis. 2001;16(5):292-297. doi: 10.1007/
s003840100308
[120] Lee MJ, Heywood N, Sagar PM, 
Brown SR, Fearnhead NS; ACPGBI 
Perianal Crohn's Disease Group. 
Association of Coloproctology of Great 
Britain and Ireland consensus exercise 
on surgical management of fistulating 
perianal Crohn's disease. Colorectal 
Dis. 2017;19(5):418-429. doi: 10.1111/
codi.13672
[121] Onali S, Calabrese E, Petruzziello C, 
Zorzi F, Sica GS, Lolli E, Ascolani M, 
Condino G, Pallone F, Biancone L. 
Endoscopic vs ultrasonographic findings 
related to Crohn's disease recurrence: a 
Outpatient Care
28
prospective longitudinal study at 3 years. 
J Crohns Colitis. 2010;4(3):319-328. doi: 
10.1016/j.crohns.2009.12.010
[122] Al-Khawari HA, Gupta R, Sinan TS, 
Prakash B, Al-Amer A, Al-Bolushi S. 
Role of magnetic resonance imaging 
in the assessment of perianal fistulas. 
Med Princ Pract. 2005;14(1):46-52. doi: 
10.1159/000081923
[123] Sandborn WJ, Fazio VW, 
Feagan BG, Hanauer SB; American 
Gastroenterological Association Clinical 
Practice Committee. AGA technical 
review on perianal Crohn's disease. 
Gastroenterology. 2003;125(5):1508-
1530. doi: 10.1016/j.gastro.2003.08.025
[124] Gecse KB, Bemelman W, Kamm MA, 
Stoker J, Khanna R, Ng SC, Panés J, van 
Assche G, Liu Z, Hart A, Levesque BG, 
D'Haens G; World Gastroenterology 
Organization, International Organisation 
for Inflammatory Bowel Diseases IOIBD, 
European Society of Coloproctology 
and Robarts Clinical Trials; World 
Gastroenterology Organization 
International Organisation for 
Inflammatory Bowel Diseases IOIBD 
European Society of Coloproctology 
and Robarts Clinical Trials. A global 
consensus on the classification, diagnosis 
and multidisciplinary treatment of 
perianal fistulising Crohn's disease. 
Gut. 2014;63(9):1381-92. doi: 10.1136/
gutjnl-2013-306709
[125] Kotze PG, Shen B, Lightner A, 
Yamamoto T, Spinelli A, Ghosh S, 
Panaccione R. Modern management 
of perianal fistulas in Crohn's disease: 
future directions. Gut. 2018;67(6):1181-
1194. doi: 10.1136/gutjnl-2017-314918
[126] Pellino G, Keller DS, 
Sampietro GM, Angriman I, Carvello M, 
Celentano V, Colombo F, Di Candido F, 
Laureti S, Luglio G, Poggioli G, Rottoli M, 
Scaringi S, Sciaudone G, Sica G, Sofo L, 
Leone S, Danese S, Spinelli A, Delaini G, 
Selvaggi F; Italian Society of Colorectal 
Surgery SICCR. Inflammatory bowel 
disease position statement of the Italian 
Society of Colorectal Surgery (SICCR): 
Crohn's disease. Tech Coloproctol. 
2020;24(5):421-448. doi: 10.1007/
s10151-020-02183-z
[127] Pellino G, Selvaggi F, Ghezzi G, 
Corona D, Riegler G, Delaini GG. A 
think tank of the Italian society of 
colorectal surgery (SICCR) on the 
surgical treatment of inflammatory 
bowel disease using the Delphi method: 
Crohn's disease. Tech Coloproctol. 
2015;19(10):639-651. doi: 10.1007/
s10151-015-1368-4
[128] Adamina M, Bonovas S, Raine T, 
Spinelli A, Warusavitarne J, Armuzzi A, 
Bachmann O, Bager P, Biancone L, 
Bokemeyer B, Bossuyt P, Burisch J, 
Collins P, Doherty G, El-Hussuna A, 
Ellul P, Fiorino G, Frei-Lanter C, Furfaro F, 
Gingert C, Gionchetti P, Gisbert JP, 
Gomollon F, González Lorenzo M, 
Gordon H, Hlavaty T, Juillerat P, 
Katsanos K, Kopylov U, Krustins E, 
Kucharzik T, Lytras T, Maaser C, Magro F, 
Marshall JK, Myrelid P, Pellino G, Rosa I, 
Sabino J, Savarino E, Stassen L, Torres J, 
Uzzan M, Vavricka S, Verstockt B, Zmora O. 
ECCO Guidelines on Therapeutics in 
Crohn's Disease: Surgical Treatment. J 
Crohns Colitis. 2020;14(2):155-168. doi: 
10.1093/ecco-jcc/jjz187
[129] Ommer A, Herold A, Berg E, 
Fürst A, Post S, Ruppert R, Schiedeck T, 
Schwandner O, Strittmatter B. German 
S3 guidelines: anal abscess and fistula 
(second revised version). Langenbecks 
Arch Surg. 2017;402(2):191-201. doi: 
10.1007/s00423-017-1563-z
[130] Koelbel G, Schmiedl U, Majer MC, 
Weber P, Jenss H, Kueper K, Hess CF. 
Diagnosis of fistulae and sinus tracts 
in patients with Crohn disease: value 
of MR imaging. AJR Am J Roentgenol. 
1989;152(5):999-1003. doi: 10.2214/
ajr.152.5.999
[131] Bouchard D, Abramowitz L, 
Bouguen G, Brochard C, Dabadie A, de 
29
Ambulatory Surgery for Perianal Disease
DOI: http://dx.doi.org/10.5772/intechopen.97119
Parades V, Eléouet-Kaplan M, Fathallah N, 
Faucheron JL, Maggiori L, Panis Y, 
Pigot F, Rouméguère P, Sénéjoux A, 
Siproudhis L, Staumont G, Suduca JM, 
Vinson-Bonnet B, Zeitoun JD. Anoperineal 
lesions in Crohn's disease: French 
recommendations for clinical practice. 
Tech Coloproctol. 2017;21(9):683-691. 
doi: 10.1007/s10151-017-1684-y
[132] Orsoni P, Barthet M,  
Portier F, Panuel M, Desjeux A, 
Grimaud JC. Prospective comparison 
of endosonography, magnetic 
resonance imaging and surgical 
findings in anorectal fistula and 
abscess complicating Crohn's disease. 
Br J Surg. 1999;86(3):360-364. doi: 
10.1046/j.1365-2168.1999.01020.x
[133] Bemelman WA, Warusavitarne J,  
Sampietro GM, Serclova Z,  
Zmora O, Luglio G, de Buck van 
Overstraeten A, Burke JP, Buskens CJ, 
Colombo F, Dias JA, Eliakim R, Elosua T, 
Gecim IE, Kolacek S, Kierkus J, Kolho KL, 
Lefevre JH, Millan M, Panis Y, Pinkney T, 
Russell RK, Shwaartz C, Vaizey C, 
Yassin N, D'Hoore A. ECCO-ESCP 
Consensus on Surgery for Crohn's 
Disease. J Crohns Colitis. 2018;12(1):1-
16. doi: 10.1093/ecco-jcc/jjx061
[134] Sibio S, Di Giorgio A, 
Campanelli M, Di Carlo S, Divizia A, 
Fiorani C, Scaramuzzo R, Arcudi C, 
Del Vecchio Blanco G, Biancone L, 
Sica G. Ambulatory Surgery for Perianal 
Crohn's Disease: Study of Feasibility. 
Gastroenterol Res Pract. 2018;5249087. 
doi: 10.1155/2018/5249087
[135] An Y, Bellato V, Konishi T,  
Pellino G, Sensi B, Siragusa L, 
Franceschilli M, Sica GS; S-COVID 
Collaborative Group. Surgeons' fear 
of getting infected by COVID19: 
A global survey. Br J Surg. 
2020;107(11):e543-e544. doi: 10.1002/
bjs.11833
[136] Bellato V, Konishi T, Pellino G, 
An Y, Piciocchi A, Sensi B, Siragusa L, 
Khanna K, Pirozzi BM, Franceschilli M, 
Campanelli M, Efetov S, Sica GS; 
S-COVID Collaborative Group. Impact 
of asymptomatic COVID-19 patients 
in global surgical practice during 
the COVID-19 pandemic. Br J Surg. 
2020;107(10):e364-e365. doi: 10.1002/
bjs.11800
[137] Sensi B, Siragusa L, Efrati C, 
Petagna L, Franceschilli M, Bellato V, 
Antonelli A, Arcudi C, Campanelli M, 
Ingallinella S, Guida AM, Divizia A. The 
Role of Inflammation in Crohn's Disease 
Recurrence after Surgical Treatment. J 
Immunol Res. 2020;2020:8846982. doi: 
10.1155/2020/8846982
[138] Sileri P, Sica G, Gentileschi P,  
Venza M, Manzelli A, Palmieri G, 
Spagnoli LG, Testa G, Benedetti E, 
Gaspari AL. Ischemic preconditioning 
protects intestine from prolonged 
ischemia. Transplant Proc. 
2004;36(2):283-285. doi: 10.1016/j.
transproceed.2004.01.078
[139] Sica, G.S., Djapardy, V., Westaby, 
S., Maynard, N.D. Diagnosis and 
management of aortoesophageal fistula 
caused by a foreign body. Annals of 
Thoracic Surgery. 2004;77(6):2217-2218 
doi: 10.1016/j.athoracsur.2003.06.031
[140] Baseman JG, Koutsky LA. The 
epidemiology of human papillomavirus 
infections. J Clin Virol. 2005;32 Suppl 
1:S16–S24. doi: 10.1016/j.jcv.2004.12.008
[141] Kreisel KM, Spicknall IH, 
Gargano JW, Lewis FM, Lewis RM, 
Markowitz LE, Roberts H, Satcher 
Johnson A, Song R, St Cyr SB, 
Weston EJ, Torrone EA, Weinstock HS. 
Sexually Transmitted Infections Among 
US Women and Men: Prevalence 
and Incidence Estimates, 2018. Sex 
Transm Dis. 2021. doi: 10.1097/
OLQ.0000000000001355.
[142] Sturegard E, Johansson H,  
Ekstrom J, Hasson BG, Johnsson A,  
Gustafsson E, Dillner J, Forslund O.  
Outpatient Care
30
Human papillomavirus typing in 
reporting condyloma. Sex Transm 
dis 2013;40:123-129. doi: 10.1097/
OLQ.0b013e31827aa9b3.
[143] Lee PK, Bas Wilkins K. Condyloma 
and other infections including human 
immunodeficiency virus. Surg clin 
N am 2010;90:99-112. doi: 10.1016/j.
suc.2009.09.005.
[144] Lacey CJN, Goodall RL, Rangarson 
Tennvall G, Maw R, Kinghorn GR, 
Fisk PG, Barton S, Byren I. Randomised 
controlled trial and economic 
evaluation of podophyllotoxin 
solution, podophyllotoxin cream, and 
podophyllin in the treatment of genital 
warts. Sex Transm Infect 2003;79:270-
275. doi: 10.1136/sti.79.4.270.
[145] Edwards A, Atma-Ram A, 
Thin RN. Podophyllotoxin 0.5% v. 
podophyllin 20% to treat penile warts. 
Genitourin Med 1988;64:263-265. doi: 
10.1136/sti.64.4.263.
[146] Tatti S, Stockfleth E, Beutner KR, 
Tawfik K, Elsasser U, Weyrauch P, 
Mescheder A. Polyphenon E: a new 
treat-ment for external anogenital 
warts. Br J dermatol 2010;162:176-184.
[147] STd Treatment Guidelines 
[Internet]. Available from: www.
cdc.gov/std/treatment/2010/genital-
warts.htm
[148] Abdullah AN, Walzman M, 
Wade A. Treatment of external genital 
warts comparing cryotherapy (liquid 
nitro-gen) and trichloroacetic acid. 
Sex Transm dis 1993;20:344-345. 
PMID: 8108758
[149] Godley MJ, Bradbeer CS, Gellan M, 
Thin RN. Cryotherapy compared with 
tricholoroacetic acid in treating geni-tal 
warts. Genitourin Med 1987;63:390-392. 
doi: 10.1136/sti.63.6.390.
[150] Balik E, Eren T, Bugra D.  
A surgical approach to anogenital 
buschke-Loewenstein tumours 
(giant condyloma acuminate). Acta 
chir belgica 2009;109:612-616. doi: 
10.1080/00015458.2009.11680497.
[151] Paraskevas KI, Kyriakos E, 
Poulios V, Stathopoulos A, Tzovaras A, 
Briana DD. Surgical management of 
giant condyloma acuminatum (Suschke-
Loewenstein tumor) of the perianal 
region. Dermatol Surg 2007;33:638-644. 
doi: 10.1111/j.1524-4725.2007.33125.x.
[152] Stone KM, Becker TM, Hadgu A, 
Kraus SJ. Treatment of external genital 
warts: a randomised clinical trial 
comparing podophyllin, cryotherapy, 
and electrodesiccation. Genitourin 
Med. 1990;66(1):16-19. doi: 10.1136/
sti.66.1.16.
